[Possibility of decreasing adverse effects of cytostatic drugs].
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000138:chemical synthesis / Q000627:therapeutic use; D001692:Biological Transport; D002463:Cell Membrane Permeability / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D004342:Drug Hypersensitivity / Q000517:prevention & control*; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D008081:Liposomes / Q000008:administration & dosage; D010455:Peptides / Q000627:therapeutic use; D011292:Premedication
D000970:Antineoplastic Agents; D006728:Hormones; D008081:Liposomes; D010455:Peptides
Mozliwość zmniejszania niepozadanych działań cytostatyków.